AbstractBackgroundObesity is a key factor in the development and progression of both heart failure with preserved ejection fraction (HFpEF) and atrial fibrillation (AF). In the STEP-HFpEF Program (…
Advances in obesity medicine are reshaping the science and practice of cardiology. JACC’s new comprehensive hub highlights the latest research, commentary, and multimedia, including a…
JACC Associate Editor Neha J. Pagidipati, MD, FACC, speaks with author Christopher M. Kramer, MD, FACC about this substudy of the SUMMIT trial published in…
Explore the key findings and clinical implications of the SUMMIT CMR Substudy in this engaging webinar. Hear from study authors Christopher M. Kramer, MD, FA…
AbstractBackgroundObesity is a known risk factor for heart failure with preserved ejection fraction (HFpEF) and is considered a distinct phenotype with more concentric remodeling. Epicardial…
Sanita Burgic, MSN, APRN, AGNP-C, of the Siteman Cancer Center at the Washington University School of Medicine in St. Louis, speaks about her JADPRO Live…
AbstractThis state-of-the-art review examines disparities in the diagnosis, management, and outcomes of cardiac arrhythmias globally. These arrhythmias include atrial fibrillation, ventricular tach…
A study examined whether the use of potassium binder sodium zirconium cyclosilicate (SZC) with dialysate potassium could reduce postdialysis heart arrhythmias.
AbstractBackgroundTwo subtypes of atrial functional mitral regurgitation (AFMR) have been described, one is characterized by Carpentier type I and the other by Carpentier type IIIb…
ACVFA Outgoing Chair Paul Weisenfeld Highlights the Committee’s Achievements, Its Role, and Its Value to Foreign Assistance The Advisory Committee on Voluntary Foreign Assistance (ACVFA)…
In a phase 1 trial presented at ASH 2024, clinical benefit was observed in 100% of patients receiving LYT-200 monotherapy.
